Shop Details

Product Image

Rs.2,547.96

Targocid 400 (Teicoplanin 400mg)

(3 customer reviews)

Targocid 400, developed by Sanofi, is a highly effective antibiotic containing Teicoplanin. It belongs to the class of glycopeptide antibiotics, used for treating severe bacterial infections, particularly those caused by Gram-positive bacteria. Its potent action against resistant strains makes it an important treatment option for healthcare providers.

Brand: Sanofi Composition: Teicoplanin 400mg

Product Introduction

Targocid 400 (Teicoplanin 400mg) is an essential antibiotic for the treatment of serious Gram-positive bacterial infections. As a glycopeptide antibiotic, it is particularly effective against methicillin-resistant Staphylococcus aureus (MRSA) and other resistant strains. By inhibiting bacterial cell wall synthesis, Targocid 400 helps in eliminating infections that are often difficult to treat.

Targocid is typically used for treating skin and soft tissue infections, pneumonia, and endocarditis caused by resistant bacteria. The ease of administration and its long half-life make it a preferred option in clinical settings. Targocid 400 has been proven to be highly effective and well-tolerated in patients.

Uses of Targocid 400 (Teicoplanin 400mg)

Targocid 400 is primarily indicated for:

service
  • Severe Skin and Soft Tissue Infections– Used in the treatment of infections caused by Gram-positive bacteria.
  • Endocarditis – Treats heart valve infections caused by resistant bacteria.
  • Pneumonia – Effective in treating pneumonia caused by Gram-positive organisms.

Targocid 400 plays a key role in managing multi-drug resistant infections, offering life-saving therapy for critically ill patients.

Side Effects of Targocid 400 (Teicoplanin 400mg)

Like any medication, Targocid 400 may cause side effects. The most common side effects include:

  • Fever
  • Rash or skin reactions
  • Gastrointestinal discomfort, including nausea
  • Injection site reactions

Less Common Side Effects

Less common side effects of Targocid 400 may include:

  • Blood disorders, such as thrombocytopenia (low platelets)
  • Liver function abnormalities
  • Renal toxicity in certain individuals

We are pleased to offer you the healthy.

Targocid 400 is a reliable antibiotic, developed by Sanofi to treat resistant bacterial infections. With the growing concerns of antibiotic resistance, Targocid 400 is essential in tackling complex infections, providing efficient and life-saving treatment.

  • The dosage is typically determined based on the infection type and severity.
  • Administered intravenously, usually once daily, or as prescribed by your doctor.
  • Duration of treatment varies depending on the type of infection.
  • It should only be used under the supervision of a healthcare provider.

Targocid 400 works by binding to the bacterial cell wall precursor and inhibiting the synthesis of the cell wall. This leads to the disruption of bacterial cell wall integrity, causing the bacteria to die. Its effectiveness against Gram-positive bacteria, especially resistant strains, makes it an essential treatment for infections that are difficult to manage.

  • Highly effective against resistant Gram-positive bacteria, including MRSA.
  • Long half-life ensures less frequent dosing and convenience for patients.
  • Well-tolerated with minimal side effects.
  • Essential for the treatment of life-threatening infections like endocarditis and pneumonia.
  • Targocid 400 should be used with caution in patients with kidney or liver problems.
  • It is not recommended for use during pregnancy unless absolutely necessary.
  • Ensure regular monitoring of kidney and liver function during treatment.

Targocid 400 (Teicoplanin 400mg) is an invaluable asset in the management of resistant bacterial infections. Its broad-spectrum activity, ease of use, and proven efficacy make it a top choice in treating severe infections. Always consult your healthcare provider for personalized treatment and monitoring.